Synapse - Zachary Epstein-Peterson

Search Within

Zachary Drew Epstein-Peterson

Results (79)

Real-world outcomes in patients with transformed follicular lymphoma treated with CD19-targeting CAR-T therapy

Meeting Abstract

Rivas-Delgado, A.; Luttwak, E.; Drill, E.; Goldstein, I.; Landego, I.; Tomas, A. A.; Parascondola, A.; Saldia, A.; Caron, P.; Dahi, P. B.; more...
Blood (2023)

Fulltext@MSK | Save

Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience

Meeting Abstract

Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
Blood (2023)

Fulltext@MSK | Save

Potent CD8+T-cell proliferation and effector differentiation following subcutaneous (SC) mosunetuzumab administration in patients with untreated, high tumor-burden follicular lymphoma (FL)

Meeting Abstract

Falchi, L.; Lin, Y. H.; Melendez, L.; Ghione, P.; Owens, C.; Hamlin, P. A.; Lue, J. K.; Epstein-Peterson, Z. D.; Kumar, A.; Palomba, M. L.; more...
Blood (2023)

Fulltext@MSK | Save

Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability

Meeting Abstract

Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
Blood (2023)

Fulltext@MSK | Save

Subcutaneous (SC) mosunetuzumab (mosun) as first-line therapy for patients (pts) with high tumor-burden follicular lymphoma (FL): First results of a multicenter phase 2 study

Meeting Abstract

Falchi, L.; Okwali, M.; Ghione, P.; Owens, C.; Hamlin, P. A.; Lue, J. K.; Epstein-Peterson, Z. D.; Palomba, M. L.; Kumar, A.; Torka, P.; more...
Blood (2023)

Fulltext@MSK | Save

Predicting toxicities in older adults with non-Hodgkin lymphoma (NHL) receiving systemic chemotherapy: A prospective geriatric assessment (GA) study

Meeting Abstract

Torka, P.; Drill, E.; Ganesan, N.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
Blood (2023)

Fulltext@MSK | Save

Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)

Meeting Abstract

Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; more...
Blood (2023)

Fulltext@MSK | Save

A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts

Meeting Abstract

Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
Bone Marrow Transplantation (2023)

Fulltext@MSK | Save

Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement

Journal Article

Ryan, C. E.; Zon, R. L.; Redd, R.; Fisher, D. C.; Shouval, R.; Kumar, A.; Crombie, J. L.; Sadrzadeh, H.; Kim, A. I.; Nayak, L.; more...
British Journal of Haematology (2023)

Fulltext@MSK | Save

Few and far between: Clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas

Review

Stuver, R.; Epstein-Peterson, Z. D.; Horwitz, S. M.
Haematologica (2023)

Fulltext@MSK | Save